Replies to post #6575 on Ariad Pharmaceuticals Inc fka ARIA

[JJM760]

I wouldn't hold my breath for Pona early approval. Most importantly, let's cross our fingers for good Rida OS data @ Asco. That would signify an "all clear" and the pps will be off to the races IMO.

FWIW, I think we will have a 10 mil offering somewhere after Asco and before the end of the year. My hope it is in the ballpark of $10+ and not before.

[BTH]

The test has always been a part of the initial trial according to Ariad. If you go back months you will see Berger saying they are going to use a diagnostic test to identify T315i so they don't run into the same problems ChemGenex ran into.